Business and Finance Business and Finance
Tue, January 28, 2025

Is Hims & Hers Health Stock a Buy?


Published on 2025-01-28 07:01:03 - AOL
  Print publication without navigation

  • For its most recently reported quarter (Q3 of 2024), Hims & Hers generated $401.6 million in revenue. That resulted in a free cash flow of $79.4 million, representing year-over-year revenue growth of 77% and free cash flow growth of 311.4%.

The article from AOL Finance discusses the recent performance and strategic moves of Hims & Hers Health, Inc. (NYSE: HIMS), a telehealth company. It highlights that Hims & Hers has seen a significant stock price increase, with shares rising over 100% in the past year. This surge is attributed to the company's expansion into new markets, including mental health and weight loss, alongside its core offerings in sexual health, dermatology, and hair loss treatments. The company has also initiated a $50 million stock buyback program, signaling strong confidence from management in its future growth prospects. Despite this optimism, the article notes that the stock's high valuation could be a concern for some investors, given the competitive landscape of the telehealth industry. However, Hims & Hers continues to focus on customer acquisition and retention, leveraging its direct-to-consumer model to drive growth.

Read the Full AOL Article at:
[ https://www.aol.com/finance/hims-hers-health-stock-buy-101000812.html ]
Contributing Sources